Preview of the 2022 Biohealth Capital Region Forum BioBuzz


BioBuzz by Workforce Genetics

The past few years in the biotech industry have been filled with both challenges and promise.

From the rapid and successful deployment of the COVID-19 vaccine and the explosion of the cell and gene therapy sector to a hiring boom, remarkable advances in tissue engineering and strong growth in biomanufacturing, the region of the biohealth capital (BHCR) played a central role in everything.

To say a lot has changed is the understatement of the century. The question remains, however: where is the BHCR going?

There’s no better way to get a glimpse into the future of the region’s life sciences ecosystem than the 8th Annual Biohealth Capital Region (BHCR) Forum, which is fast approaching. not. The 2022 BHCR Forum is a can’t-miss in-person/live-streamed event being held at United States Pharmacopeia (USP) in Rockville, Maryland on September 20e. Also, September 21st at the USP will be the 5e Annual Biohealth Capital Region Investment Conference and 7th Annual Crab Trap Contest.

Each year, top thought leaders and subject matter experts from BHCR and beyond come together to discuss global trends and industry growth in Maryland, DC and Virginia, as well as the purpose to become one of the three main American biotechnology clusters by 2023. .

The BHCR Forum is free for executive-level biotech leaders and will feature engaging keynotes and discussions, including speakers from NIH, BARDA, CEPI, TEDCO, Children’s National Hospital, JLABS, and numerous biohealth industry representatives. . There will be great networking opportunities and an informative update on the Top 10 GEN Bioclusters by Alex Philippidis, Senior Business Editor of Genetic Engineering and Biotechnology News.

The BHCR Forum is organized by the following event partners: The Association of University Research Parks; Astra Zeneca; Biohealth innovation; BRAINBox Solutions, Inc, Children’s National Hospital; ; George Mason University; Johnson & Johnson Innovation – JLABS @ Washington, DC; the Maryland Department of Commerce, MCEDC, REDI and Virginia Bio.

The one-day event will be accessible with in-person attendance and live streaming, and will include the following special sessions in addition to a host of breakout panels throughout the day:

  • Keynote address by BHI’s Rich Bendis on “Imagine the Future Together”
  • A Fireside Chat on the Biohealth Investment Climate with BHI’s Rich Bendis and Joel Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities, Inc.
  • A speech by Gary Disbrow, director of the Biomedical Advanced Research and Development Authority (BARDA)
  • Diversity, Equity and Inclusion with Maurice Jones, CEO of OneTen
  • Next Generation Immunity with Stu Soloman, President and CEO, Connected DMV
  • A keynote address by Matt McMahon, Director of the NIH Small Business Education and Entrepreneurial Development SEED Program

Focus group topics will include:

Infectious Disease Resources for Research and Development

Local and regional resources are available to support research and development of countermeasures to combat infectious diseases, including priority pathogens for national and global pandemic preparedness. Learn about opportunities to access in vitro and in vivo services in BSL-3 and BSL-4 environments, how to access them, and how the teams can help you advance your new therapeutic, vaccine, and diagnostic pipelines.

How Standards Help Bring New Medicines to Market: An Introduction to the U.S. Pharmacopoeia

For more than 200 years, the United States Pharmacopeia (USP) has set standards that help bring new medicines to market by supporting regulatory predictability in manufacturing and innovation. In this session, you will learn about USP, the standards they work on to support new drugs such as mAbs and vaccines, and how they help overcome barriers to the adoption of new drug technologies. manufacturing. The discussion will also include a new biopharmaceutical company’s perspective on how standards help bring new drugs to market.

The FDA Centers for Regulatory Science and Innovation

Based in White Oak, Maryland, the FDA is the world’s leading regulator of drugs and devices and is committed to helping bring innovative, safe, and effective treatments and cures to patients who need them as quickly as possible. Learn how the FDA, through the Center for Devices and Radiological Health (CDRH) and the Extramural Centers for Regulatory Science and Innovation (CERSI), works with research hospitals, academic medical centers, and the industry to foster innovations in the life sciences.

Regional Support for BioHealth Entrepreneurs

The Biohealth Capital Region is a stimulating space for innovators, researchers and problem solvers. In the region’s three jurisdictions (DC, Maryland, and Virginia), local startups can find technical assistance, lab infrastructure, mentorship, and funding from private and public sector partners. Learn more about the resources available in BHCR’s entrepreneurial ecosystem as you commercialize your technology and grow your business.

Environmental Stewardship and Sustainability in the Biohealth Industry

Innovation within the BioHealth industry can provide global solutions to environmental challenges, such as climate change and biodiversity loss. Leadership in sustainable business operations can also reduce laboratory and facility energy consumption and waste. In some cases, local life sciences leaders are going even further and reinventing their corporate structure to include a commitment not only to shareholders but also to patients, the planet, their employees and our communities..

Innovation through collaboration: Opportunities in the BHCR

Successful BioHealth companies understand that collaboration is the key to solving our most pressing health issues. From incubation to open innovation to investing in start-ups, the biohealth capital region’s private sector is brimming with partnerships, knowledge transfer and opportunities to accelerate research to save more lives faster. Hear from the region’s top life science companies and labs about how they foster collaboration with external researchers and innovators – your company could be next!

Biohealth companies still have time to apply for both the Biohealth Capital Region Investment Conference and the Crab Trap on September 21st.


About Author

Comments are closed.